TRIB2 is elevated in a subset of AML patient samples and TRIB2 has been identified as an oncogene capable of inducing AML in mice by inhibiting the transcription factor C/EBPα [13]. The gene discussed is CEBPA; the disease is acute myeloid leukemia.